It’s been a year since we’ve heard of a major health threat to your life, but we’ve learned that the first case of a severe, life-threatening illness caused by a drug that makes people sleepy is still spreading.
That’s according to the Food and Drug Administration (FDA) on Monday, when it announced the first confirmed case of an infection caused by the sleeping pill Naloxone, which is used to revive those in need of an opioid overdose.
The first case was confirmed in December, and the FDA says the new case is just the tip of the iceberg.
The FDA is also warning about the dangers of using sleeping pills as an opioid treatment, as well as taking an overdose of the sleeping pills or taking them in large quantities.
The drug was approved in the US for emergency use only, but its use is growing across the world.
In November, it was approved for use in Australia, France, Canada, Denmark, Iceland, the Netherlands, Norway, the UK, Sweden, Switzerland, and Thailand.
According to the FDA, the drug’s manufacturer, Purdue Pharma, has been notified of the first new case of serious illness in nearly a year, and is investigating the case further.
“This is just a first step in the investigation,” FDA Commissioner Margaret Hamburg told reporters on Monday.
“We want to make sure that this does not occur again and that we’re not overburdening the system.”
“There’s no known way to prevent an infection when someone takes the drug, but there are ways to prevent overdose.”
Hamburg said the FDA is still investigating how Nalaxone interacts with other drugs in the body, and that the agency is also investigating whether the drug is effective as a treatment for Parkinson’s disease.
The CDC and FDA are also investigating the use of Naluxone as a preventative measure against the flu, and Nalixor has been given a green light for use as a cough suppressant.
The new case comes just months after the CDC warned people to be cautious about using Naloxy and Nalgene.
The FDA says Naloxin, Nalex, and Nexnex have been found to be associated with an increased risk of infection, and are considered sedatives that are used for anesthesia.
The agency said the case of the new infection is just one of many that have come to light since the flu season started, with more than 20,000 new cases reported since the start of the year.
The latest cases are being investigated by the FDA’s National Center for Emerging and Zoonotic Infectious Diseases and the CDC’s National Centre for Emerging & Zoonotistic Infectious Disease.